HGH Fragment 176-191
HGH Fragment 176-191 is a weight management peptide used in evidence-based, physician-supervised protocols. Use for targeted fat loss without anabolic side effects.
What is HGH Fragment 176-191?
C-terminal fragment of HGH. Activates beta-3 adrenergic receptors on adipocytes to stimulate lipolysis. Does NOT bind GH receptors — no IGF-1 elevation, no anabolic effects, no glucose dysregulation. Pure fat-burning fragment.
Uses & clinical decision logic
Use for targeted fat loss without anabolic side effects. Safe for diabetics. Best results with fasted administration (BID: morning fasted + pre-bed fasted). Run 4-12 week cycles.
HGH Fragment 176-191 dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 5mg | 2mL | 250-500mcg | 10-20 units | BID (morning fasted + pre-bed) | SubQ |
Safety & contraindications
Minimal — favorable safety profile. Ensure fasted state for both doses.
Stacking & combinations
Compatible with GLP-1 agents, AOD-9604, GH peptides. Pairs with GHRP/GHRH during recomposition.
Related peptides
Frequently asked questions
What is HGH Fragment 176-191 used for?
Use for targeted fat loss without anabolic side effects. Safe for diabetics. Best results with fasted administration (BID: morning fasted + pre-bed fasted). Run 4-12 week cycles.
What is the typical HGH Fragment 176-191 dosage?
Common dosing ranges from 250-500mcg (BID (morning fasted + pre-bed), SubQ). Exact dosing is individualized and set by a licensed physician.
How is HGH Fragment 176-191 administered?
HGH Fragment 176-191 is typically administered via SubQ.
What are the contraindications for HGH Fragment 176-191?
Minimal — favorable safety profile. Ensure fasted state for both doses.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.